News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Stem Cell Theranostics' "Clinical-Trial-in-a-Dish" Wows



9/13/2013 8:13:31 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Stem Cell Theranostics has developed what it calls “clinical trials in a dish,” with the goal of weeding out toxic compounds early in development and saving pharmaceutical companies, patients and hospitals billions of dollars. Particularly, it’s focused on heart disease. The biotech is developing technology that would let researchers grow heart cells in a dish from skin cell-derive pluripotent stem cells. That would give them a cheaper, faster and more accurate way to screen drugs for efficacy and toxicity.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES